JAM
JW Asset Management Portfolio holdings
AUM
$203M
This Quarter Return
+1.77%
1 Year Return
+14.62%
3 Year Return
+92.55%
5 Year Return
+369.07%
10 Year Return
+1,148.19%
AUM
$261M
AUM Growth
+$261M
(+7.2%)
Cap. Flow
+$12.3M
Cap. Flow
% of AUM
4.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
2
Reduced
–
Closed
2
Top Buys
| 1 |
Eli Lilly
LLY
|
$9.27M |
| 2 |
Novo Nordisk
NVO
|
$2.32M |
| 3 |
FAZE
FaZe Holdings Inc. Common Stock
FAZE
|
$1.44M |
| 4 |
Idaho Strategic Resources
IDR
|
$266K |
Top Sells
| 1 |
MSAC
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
|
$1.01M |
| 2 |
MSACW
Medicus Sciences Acquisition Corp. Warrant
MSACW
|
$1K |
Sector Composition
| 1 | Healthcare | 95.87% |
| 2 | Consumer Staples | 3.07% |
| 3 | Communication Services | 0.55% |
| 4 | Materials | 0.51% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $216M | 83% |
3,192,485
| – | – |
|
|
2
Novo Nordisk
NVO
$251B
| $9.41M | 3.61% |
59,100
+14,600
| +33% | +$2.32M |
|
3
Catalyst Pharmaceutical
CPRX
$2.52B
| $9.34M | 3.58% |
563,392
| – | – |
|
|
4
Eli Lilly
LLY
$657B
| $9.27M | 3.56% |
+27,000
| New | +$9.27M |
|
5
Celsius Holdings
CELH
$16.2B
| $8M | 3.07% |
86,038
| – | – |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.53M | 2.12% |
50,673
| – | – |
|
|
FAZE
7
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $1.44M | 0.55% |
+3,126,319
| New | +$1.44M |
|
|
8
Idaho Strategic Resources
IDR
$408M
| $1.32M | 0.51% |
271,697
+54,546
| +25% | +$266K |
|
|
MSACW
9
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
| – | – |
-11,110
| Closed | -$1K |
|
|
MSAC
10
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| – | – |
-100,000
| Closed | -$1.01M |
|